Health-Related Quality of Life of Moroccan COVID-19 Survivors: A Case-Control Study

Asmaa Azizi, Doha Achak, Elmadani Saad, Abderraouf Hilali, Chakib Nejjari, Mohamed Khalis, Ibtissam Youlyouz-Marfak and Abdelghafour Marfak
Additional contact information
Asmaa Azizi: Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco
Doha Achak: Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco
Elmadani Saad: Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco
Abderraouf Hilali: Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco
Chakib Nejjari: International School of Public Health, Mohammed VI University of Health Sciences, Casablanca 82403, Morocco
Mohamed Khalis: International School of Public Health, Mohammed VI University of Health Sciences, Casablanca 82403, Morocco
Ibtissam Youlyouz-Marfak: Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco
Abdelghafour Marfak: Laboratory of Health Sciences and Technologies, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26000, Morocco

IJERPH, 2022, vol. 19, issue 14, 1-19

Abstract: Background: Research on COVID-19 has mostly focused on transmission, mortality and morbidity associated with the virus. However, less attention has been given to its impact on health-related quality of life (HRQoL) of patients with COVID-19. Therefore, this study aimed to determine the demographic and clinical risk factors associated with COVID-19 and evaluate its impact on the HRQoL of COVID-19 survivors. Methods: A case-control study was carried out between September 2021 and March 2022 on 1105 participants. A total of 354 were COVID-19 survivors and 751 were the control group. The HRQoL was assessed using both EQ-5D-5L and SF-6D generic instruments. Results: The average age of all participants was 56.17 ± 15.46. Older age, urban area, tobacco use, presence of chronic diseases especially type 1 diabetes, kidney and cardiovascular diseases were significantly associated with COVID-19. The COVID-19 survivors had significantly lower HRQoL (EQ-VAS = 50.89) compared to the control group (EQ-VAS = 63.36) ( p -value < 0.0001). Pain/ discomfort and anxiety/depression were the most negatively affected by COVID-19 ( p -value < 0.0001). Conclusions: The findings from this study could help healthcare professionals and policy makers to better understand the HRQoL sequelae among the COVID-19 survivors and contribute to develop tailored interventions.

Keywords: COVID-19; health related quality of life; EQ-5D-5L; SF-6D; anxiety; depression; pain (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/14/8804/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/14/8804/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:14:p:8804-:d:866957

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().